Aquestive Therapeutics AQST
NASDAQ AQST
$3.58 +0.06 (+1.70%)
At close: Nov 11, 2026 · 4:00 PM EST

Aquestive Therapeutics (AQST) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Aquestive Therapeutics (AQST) recorded Return on Capital Employed [ROCE] of -51.41% in Q3 2026, up 2.73 percentage points from -54.14% a year earlier but down 7.50 percentage points from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Aquestive Therapeutics reported Return on Capital Employed [ROCE] of -85.28%, down 34.46 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of +1.24 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -50.81% in FY2024 (-12.03 pp), -38.79% in FY2023 (+171.51 pp), -210.29% in FY2022 (-124.61 pp) and -85.68% in FY2021 (+0.84 pp).
  • Quarterly Return on Capital Employed [ROCE] has ranged from -281.76% in Q4 2022 to -13.85% in Q2 2024 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased for three consecutive quarters, with an average year-over-year change of -13.21 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 244.13 percentage points in Q4 2023, against a drop of 198.56 percentage points in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -43.90% (Q2 2026), -46.96% (Q1 2026) and -62.12% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Aquestive Therapeutics 442.42 Mn 21.68 Mn 3.95 Mn -51.41%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -51.41%
Jun 30, 2026 -43.90%
Mar 31, 2026 -46.96%
Dec 31, 2025 -62.12%
Sep 30, 2025 -54.14%
Jun 30, 2025 -70.31%
Mar 31, 2025 -49.30%
Dec 31, 2024 -35.44%
Sep 30, 2024 -21.40%
Jun 30, 2024 -13.85%
Mar 31, 2024 -25.80%
Dec 31, 2023 -37.64%
Sep 30, 2023 -64.11%
Jun 30, 2023 -138.53%
Mar 31, 2023 -196.51%
Dec 31, 2022 -281.76%
Sep 30, 2022 -245.59%
Jun 30, 2022 -157.32%
Mar 31, 2022 -102.32%
Dec 31, 2021 -83.20%
API Access

Aquestive Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AQST&period=max&api_key=YOUR_API_KEY